![](/images/graphics-bg.png)
Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome
المؤلفون المشاركون
Jiang, Chunming
Shao, Qiuyuan
Jin, Bo
Gong, Rujun
Xu, Biao
Zhao, Min
Xie, Jun
Xia, Yangyang
Liu, Jing
Zhang, Qingyan
المصدر
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-9، 9ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-05-17
دولة النشر
مصر
عدد الصفحات
9
التخصصات الرئيسية
الملخص EN
Aims.
To evaluate the effectiveness and safety of peritoneal dialysis (PD) in treating refractory congestive heart failure (RCHF) with cardiorenal syndrome (CRS).
Methods.
A total of 36 patients with RCHF were divided into type 2 CRS group (group A) and non-type 2 CRS group (group B) according to the patients’ clinical presentations and the ratio of serum urea to creatinine and urinary analyses in this prospective study.
All patients were followed up till death or discontinuation of PD.
Data were collected for analysis, including patient survival time on PD, technique failure, changes of heart function, and complications associated with PD treatment and hospitalization.
Results.
There were 27 deaths and 9 patients quitting PD program after a follow-up for 73 months with an average PD time of 22.8±18.2 months.
A significant longer PD time was found in group B as compared with that in group A (29.0±19.4 versus 13.1±10.6 months, p=0.003).
Kaplan–Meier curves showed a higher survival probability in group B than that in group A (p<0.001).
Multivariate regression demonstrated that type 2 CRS was an independent risk factor for short survival time on PD.
The benefit of PD on the improvement of survival and LVEF was limited to group B patients, but absent from group A patients.
The impairment of exercise tolerance indicated by NYHA classification was markedly improved by PD for both groups.
The technique survival was high, and the hospital readmission was evidently decreased for both group A and group B patients.
Conclusions.
Our data suggest that PD is a safe and feasible palliative treatment for RCHF with type 2 CRS, though the long-term survival could not be expected for patients with the type 2 CRS.
Registration ID Number is ChiCTR1800015910.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Shao, Qiuyuan& Xia, Yangyang& Zhao, Min& Liu, Jing& Zhang, Qingyan& Jin, Bo…[et al.]. 2018. Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. BioMed Research International،Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1127981
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Shao, Qiuyuan…[et al.]. Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. BioMed Research International No. 2018 (2018), pp.1-9.
https://search.emarefa.net/detail/BIM-1127981
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Shao, Qiuyuan& Xia, Yangyang& Zhao, Min& Liu, Jing& Zhang, Qingyan& Jin, Bo…[et al.]. Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1127981
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1127981
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)